biosimilar antibody
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://doi.org/10.7910/DVN/OAYQAI
下载链接
链接失效反馈官方服务：
资源简介：
Biologics are critical components in the treatment of patients with cancer. Biosimilars - biologics that are highly similar to approved biologics - offer a potential opportunity to increase access to biologics by stimulating price competition and may lower healthcare costs. The active substance of a biosimilar and the original (approved medicine) are essentially the same biological substance, though there may be minor differences due to their complex nature and the production methods.
创建时间：
2023-06-18
